hydroxychloroquine has been researched along with Mucositis, Oral in 7 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
Excerpt | Relevance | Reference |
---|---|---|
"Chronic ulcerative stomatitis (CUS) is a rare disease of the mucous membranes with characteristics similar to other autoimmune diseases." | 2.82 | Clinical and immunological features of chronic ulcerative stomatitis: A systematic review. ( Palma, VM; Rados, PV; Schroeder, FMM; Visioli, F, 2022) |
" A distinguishing feature of CUS is the low response to conventional corticosteroid therapy and the good outcome with hydroxychloroquine at the dosage of 200 mg/day or higher dosages." | 2.61 | Chronic ulcerative stomatitis: A comprehensive review and proposal for diagnostic criteria. ( Azzi, L; Cerati, M; Croveri, F; Lombardo, M; Maurino, V; Olszewska, M; Pellilli, M; Tagliabue, A; Tettamanti, L, 2019) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Schroeder, FMM | 1 |
Palma, VM | 1 |
Rados, PV | 1 |
Visioli, F | 1 |
Wang, Q | 1 |
Luo, M | 1 |
Xiang, B | 1 |
Chen, S | 1 |
Ji, Y | 1 |
Stoopler, ET | 1 |
Kulkarni, R | 1 |
Alawi, F | 1 |
Sollecito, TP | 1 |
Azzi, L | 1 |
Cerati, M | 1 |
Lombardo, M | 1 |
Pellilli, M | 1 |
Croveri, F | 1 |
Maurino, V | 1 |
Tagliabue, A | 1 |
Tettamanti, L | 1 |
Olszewska, M | 1 |
Wu, YH | 1 |
Chang, JY | 1 |
Chen, HM | 1 |
Wang, YP | 1 |
Islam, MN | 1 |
Cohen, DM | 1 |
Ojha, J | 1 |
Stewart, CM | 1 |
Katz, J | 1 |
Bhattacharyya, I | 1 |
Lloyd, DD | 1 |
Balfe, JW | 1 |
Barkin, M | 1 |
Gelfand, EW | 1 |
4 reviews available for hydroxychloroquine and Mucositis, Oral
Article | Year |
---|---|
Clinical and immunological features of chronic ulcerative stomatitis: A systematic review.
Topics: Animals; Autoimmune Diseases; Chronic Disease; Female; Fluorescent Antibody Technique, Indirect; Gin | 2022 |
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combinat | 2020 |
Chronic ulcerative stomatitis: A comprehensive review and proposal for diagnostic criteria.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Antinuclear; Female; Gingivitis, Necrotizing Ulcerative; | 2019 |
Chronic ulcerative stomatitis: diagnostic and management challenges--four new cases and review of literature.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dermatologic Agents; Female; Fluorescent Antibody T | 2007 |
3 other studies available for hydroxychloroquine and Mucositis, Oral
Article | Year |
---|---|
Novel combination therapy of hydroxychloroquine and topical tacrolimus for chronic ulcerative stomatitis.
Topics: Administration, Topical; Chronic Disease; Combined Modality Therapy; Humans; Hydroxychloroquine; Imm | 2021 |
Pyostomatitis vegetans: An oral manifestation of inflammatory bowel disease.
Topics: Adult; Colchicine; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Inflammatory Bowel | 2015 |
Systemic lupus erythematosus with signs of retroperitoneal fibrosis.
Topics: Adolescent; Beta-Globulins; Complement System Proteins; Cyclophosphamide; Female; Glomerulonephritis | 1974 |